Horizon Discovery grants a multi-product use license of its GS knockout CHO K1 cell line to NGM Bio
January 21, 2020
Cell line to be used to support research and development of biotherapeutics across therapeutic areas Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will license its gene-edited Glutamine Synthetase [...]
January 21, 2020
Introducing the Dynamic Void Volume Analyzer (DVVA) II for automated, environmentally benign testing, for rubber compounding Norcross, GA, USA — Micromeritics Instrument Corp., a leader in material characterization technology, has developed an optimized, automated solution for customers looking to characterize carbon blacks in accordance with the newly revised ASTM D1765-18 Classification System for Carbon Blacks [...]
January 21, 2020
SAN DIEGO — COBO Technologies and Cardea Bio partner to bring solutions to challenges with the precision of Genome editing. The partners have agreed to co-develop and market a portfolio of CRISPR QC products and services for quality control (QC) of CRISPR research, agricultural, and pre-clinical programs. Over the longer-term, the parties aim to develop a [...]
Genomenon’s Mastermind Continues to Outpace Qiagen’s HGMD Genetic Database
January 21, 2020
ANN ARBOR, Mich. — Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. This number reflects the rapidly accelerating pace of genomic discovery, and stands in stark contrast [...]
CellFE Raises $3.6M in Seed Round Co-led by Cota Capital and Dynamk Capital
January 16, 2020
SAN CARLOS, Calif., Jan. 16, 2020 — CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has raised $3.6 million in an initial Series Seed. The oversubscribed round is co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures. The round is expected to close with additional investors [...]
January 16, 2020
( Berlin,16/1/20) From January 27th to 29th the International Sales Meeting will take place at the headquarters of LUM GmbH in Berlin-Adlershof for the 21st time in a row. The sales experts of the LUM companies from Asia, Europe and North America exchange technical information with external sales partners from all over the world. This is where [...]
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
January 16, 2020
SANTA CLARA, Calif.– Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children and one in 12 adults. The aim of the collaboration is to help the medical [...]
Discover 18 Wells for Cost-Effective Cell Culture and High-Resolution Microscopy
January 16, 2020
Munich, Germany – Perform high-resolution, cost-effective cell culture experiments with ibidi’s latest innovative labware technology, the µ-Slide 18 Well family. With its thin ibidi Polymer Coverslip Bottom, the µ-Slide 18 Well allows for excellent cell adhesion onto the tissue culture-treated surface. In addition, it has the highest optical quality and is ideally suited for a variety of [...]
January 15, 2020
— Contract Focused on Making DNA Data Storage Commercially Accessible — SAN FRANCISCO– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has been selected as a subcontractor to Georgia Tech Research Institute (GTRI) to undertake the DNA [...]
Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery
January 15, 2020
SOUTH SAN FRANCISCO, Calif.–Jan. 15, 2020– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ [...]
